As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Dwivedi, Varun
The major goal is to evaluate antiviral activity of CUSTOMER COMPOUND against SARS-CoV-2 in Vero cell lines.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Torrelles, Jordi B
Funded by
Airway Therapeutics
The goal is to determine the effectivity of AT-100 post-infection in blocking SARS-CoV-2 infectivity.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
San Antonio Partnership for Precision Therapeutics
The major goal of this study is to develop a vaccine against COVID-19 by creating a recombinant Francisella bacterium that expresses SARS-CoV-2 spike protein.
Southwest Research Institute (SwRI), headquartered in San Antonio, Texas, is one of the oldest and largest independent, nonprofit, applied research and development (R&D) organizations in the United States.
Principal Investigator(s)
Dr. Kenneth Carson
Funded by
San Antonio Partnership for Precision Therapeutics
Collaborating Institutions
South Texas Center for Emerging Infectious Diseases
UT Health San Antonio
Texas Biomedical Research Institute
The San Antonio Partnership for Precision Therapeutics has awarded $200,000 for a collaborative study to develop a novel vaccine to combat COVID-19. Within days of the Stay Home/Work Safe directive issued by the City of San Antonio, the San Antonio Partnership for Precision Therapeutics (SAPPT) organized and issued a call for proposals to combat COVID-19.
